Vital Therapies (VTL) Reports In-Line Q3 EPS

Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
• Aecon wins $1.7B share of Alberta power plant contract